CYTORI THERAPEUTICS INC - COM (CYTX)

CUSIP: 23283K105

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
16,388,269
Share change
-907,222
Total reported value
$19,334,109
Price per share
$1.18
Number of holders
61
Value change
+$1,105,243
Number of buys
31
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 23283K105?
CUSIP 23283K105 identifies CYTX - CYTORI THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM (CYTX) as of Q1 2015

As of 31 Mar 2015, CYTORI THERAPEUTICS INC - COM (CYTX) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,388,269 shares. The largest 10 holders included BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, PERKINS CAPITAL MANAGEMENT INC, STATE STREET CORP, NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, PRINCETON CAPITAL MANAGEMENT INC, and TIAA CREF INVESTMENT MANAGEMENT LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.